ASH 2018 Emanuele Angelucci

Emanuele Angelucci, MD
Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy


Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study



Ask Speakers


Medical Information Request